Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Janus

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 14, 2007
Letter. Systemic anticancer therapy in gynecological cancer patients with renal dysfunctionV Launay-Vacher, N Janus, S Karie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2010
Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patientsN Janus, J Thariat, H Boulanger, et al.
Annales De Cardiologie Et D'Angeiologie|May 27, 2014
[Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients]S Zimner-Rapuch, S Amet, N Janus, et al.
La Revue De Medecine Interne|April 16, 2011
[aMDRD formula is the method of choice for estimating the glomerular filtration rate, even in the "very old": comment on the article by Andro et al]V Launay-Vacher, S Zimner-Rapuch, S Amet, et al.
Journal Des Maladies Vasculaires|December 29, 2016
Renal function and venous thromboembolic diseasesN Janus, I Mahé, V Launay-Vacher, et al.
Medecine Et Maladies Infectieuses|November 13, 2007
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency]N Janus, V Launay-Vacher, H Izzedine, et al.
Rheumatology (Oxford, England)|February 2, 2008
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyS Karie, F Gandjbakhch, N Janus, et al.
Journal De Medecine Vasculaire|June 12, 2022
Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE studyC Frere, B Crichi, J A Rueda-Camino, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 28, 2009
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]N Janus, V Launay-Vacher, C Robert, et al.
British Journal of Cancer|November 11, 2010
Cancer and renal insufficiency results of the BIRMA studyN Janus, V Launay-Vacher, E Byloos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 14, 2007
Letter. Systemic anticancer therapy in gynecological cancer patients with renal dysfunctionV Launay-Vacher, N Janus, S Karie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2010
Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patientsN Janus, J Thariat, H Boulanger, et al.
Annales De Cardiologie Et D'Angeiologie|May 27, 2014
[Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients]S Zimner-Rapuch, S Amet, N Janus, et al.
La Revue De Medecine Interne|April 16, 2011
[aMDRD formula is the method of choice for estimating the glomerular filtration rate, even in the "very old": comment on the article by Andro et al]V Launay-Vacher, S Zimner-Rapuch, S Amet, et al.
Journal Des Maladies Vasculaires|December 29, 2016
Renal function and venous thromboembolic diseasesN Janus, I Mahé, V Launay-Vacher, et al.
Medecine Et Maladies Infectieuses|November 13, 2007
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency]N Janus, V Launay-Vacher, H Izzedine, et al.
Rheumatology (Oxford, England)|February 2, 2008
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyS Karie, F Gandjbakhch, N Janus, et al.
Journal De Medecine Vasculaire|June 12, 2022
Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE studyC Frere, B Crichi, J A Rueda-Camino, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 28, 2009
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]N Janus, V Launay-Vacher, C Robert, et al.
British Journal of Cancer|November 11, 2010
Cancer and renal insufficiency results of the BIRMA studyN Janus, V Launay-Vacher, E Byloos, et al.
Pageof 2